VEGFA and Parkinson disease: The ALT-like type was enriched for NABA ECM-affiliated pathways and regulation of lymphocyte activation, and the NDTMM type was enriched for Parkinson’s disease, neutrophil degranulation, and vascular endothelial growth factor-alpha (VEGFA) signaling pathways (Figure 3A).